Every major AI model failed to generate an appropriate differential diagnosis more than 80% of the time. Give them all the test results, though, and they nail the answer. The gap between those two numbers is the whole story.
A once-daily pill cut the risk of death by 60 percent in metastatic pancreatic cancer — 13.2 months versus 6.7 months on chemotherapy. The FDA could review it within months.
After a decade of failed treatments and daily blood transfusions, a single CAR-T cell infusion put three autoimmune diseases into remission. Fourteen months later, the patient takes no medication.
A CDC study found the latest COVID shots cut hospitalizations by 55% in healthy adults. Acting director Jay Bhattacharya blocked its release — citing methodology the agency has used to evaluate flu vaccines for two decades.
Two major insurers dropped Moffitt Cancer Center from Medicare Advantage in six months. The reasons were business, not clinical — and patients already in treatment are paying the price.
Fifty generic semaglutide products hit Indian pharmacies the day after the Ozempic patent expired. Gym trainers and beauticians are already prescribing them.
Nearly a quarter of patients on blockbuster weight-loss drugs lose little or nothing. A genetic study of 28,000 people published today in Nature begins to explain why — and could eventually let doctors test whether the drugs will work before prescribing them.
For decades, KRAS mutations were a death sentence wrapped in a smooth protein surface. Now degraders and multi-target inhibitors are advancing through clinical trials — and the first results are due within months.
A federal judge said Kennedy's ACIP appointees were unqualified. His solution: change the qualifications. A single added word in the new charter could let the HHS Secretary unilaterally install members.
More than 100 suspected measles deaths in under a month. Bangladesh's emergency vaccination campaign is racing to close immunity gaps that widened through years of political upheaval and missed catch-up drives.
DEHP, a chemical found in everything from shampoo to cling wrap, may have contributed to nearly two million premature births in a single year. The heaviest toll falls on regions least equipped to handle it.
The US State Department gave staff in 17 African countries and Haiti six weeks to wind down the supply chain that has delivered $5 billion in HIV and malaria products since 2016. The transition plan is: write your own.
British families used commercial DNA tests to discover their children were conceived with the wrong donors. The clinics they trusted answer to almost nobody.
The average person swallows roughly 4,000 microplastic particles a year through drinking water alone. The EPA just put the stuff on a list. That's it — just a list.
A 30-year-old man with no travel history has Singapore's first locally transmitted clade 1b mpox case. The virus was already circulating before anyone noticed.
Lilly's Foundayo can be taken anytime, with or without food. Its biggest rival requires an empty stomach and a 30-minute wait.
The cardiovascular benefit appeared before patients lost any weight — suggesting the drug works directly on the heart, not the waistline. Now 1.2 million NHS patients are about to find out what that means.
Seven children conceived with the wrong sperm and egg donors at clinics in Northern Cyprus. The territory has no independent fertility regulator — and the doctor linked to every case says she wasn't responsible.
A comprehensive review spanning animal studies, human cases, and lab work concludes nicotine e-cigarettes likely cause cancer — and warns regulators not to wait decades for definitive proof like they did with cigarettes.
Japan has only four approved ADHD medications. When two became unavailable, patients had nowhere to go — and a country learning to recognize neurodivergence discovered its pharmaceutical infrastructure was never built for the moment.
lop News
Carl Sage